Sepsis | Urosepsis

36- Sepsis and Critical Illness Research Center investigators- protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients

Apr 4, 2024

440- Central Line-Associated Bloodstream Infection (CLABSI)

Mar 15, 2022

439- Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection)

Mar 15, 2022

438- Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City

Mar 15, 2022

419- Risk Factors for Urosepsis in Older Adults- A Systematic Review

Mar 15, 2022

416- Risk Factors for 30-Day Hospital Readmission among General Surgery Patients – ScienceDirect

Mar 15, 2022

414- The Unrecognized Threat of Secondary Bacterial Infections with COVID-19

Mar 15, 2022

413- Sepsis update 2019 Slide deck

Mar 15, 2022

412- Sepsis-induced immune dysfunction- Can immune therapies reduce mortality?

Mar 15, 2022

398- Readmissions Due to Hospital-Acquired Conditions (HACs)

Mar 15, 2022

1
2
3
4

U.S. and International Patents and Patents Pending. © 2025 Swan Valley Medical, Incorporated. All Rights Reserved. T-SPeC® and the Swan icon are registered trademarks of Swan Valley Medical, Incorporated.